IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes
Open Access
- 23 August 2006
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 81 (11), 824-831
- https://doi.org/10.1002/ajh.20656
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemiaLeukemia Research, 2004
- Overcoming Drug Resistance in Multiple Myeloma: The Emergence of Therapeutic Approaches to Induce ApoptosisJournal of Clinical Oncology, 2003
- CRM1-Mediated Nuclear Export Determines the Cytoplasmic Localization of the Antiapoptotic Protein SurvivinExperimental Cell Research, 2002
- Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosaHuman Pathology, 2001
- An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7Biochemistry, 2001
- Multidrug resistance in haematological malignanciesJournal of Internal Medicine, 2000
- Analysis of human transcriptomesNature Genetics, 1999
- The inhibitors of apoptosis (IAPs) and their emerging role in cancerOncogene, 1998
- Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genesNature, 1996
- The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteinsCell, 1995